| mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance L Garros-Regulez, P Aldaz, O Arrizabalaga, V Moncho-Amor, ... Expert opinion on therapeutic targets 20 (4), 393-405, 2016 | 138 | 2016 |
| Targeting SOX2 as a therapeutic strategy in glioblastoma L Garros-Regulez, I Garcia, E Carrasco-Garcia, A Lantero, P Aldaz, ... Frontiers in oncology 6, 222, 2016 | 122 | 2016 |
| Open access of COVID-19 O Arrizabalaga, D Otaegui, I Vergara, J Arrizabalaga, E Méndez Related Publications in the First Quarter of, 2020 | 47 | 2020 |
| Increased gene dosage of Ink4/Arf and p53 delays age‐associated central nervous system functional decline E Carrasco‐Garcia, O Arrizabalaga, M Serrano, R Lovell‐Badge, ... Aging Cell 14 (4), 710-714, 2015 | 44 | 2015 |
| High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response O Arrizabalaga, L Moreno-Cugnon, J Auzmendi-Iriarte, P Aldaz, ... Oncogenesis 6 (12), 401, 2017 | 27 | 2017 |
| Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMed O Arrizabalaga, D Otaegui, I Vergara, J Arrizabalaga, E Méndez F1000Research 9, 2020 | 22 | 2020 |
| Neuronal p38α mediates age‐associated neural stem cell exhaustion and cognitive decline L Moreno‐Cugnon, M Revuelta, O Arrizabalaga, S Colie, ... Aging Cell 18 (6), e13044, 2019 | 20 | 2019 |
| Therapeutic strategies targeting glioblastoma stem cells E Carrasco-Garcia, N Sampron, P Aldaz, O Arrizabalaga, J Villanua, ... Recent Patents on Anti-Cancer Drug Discovery 8 (3), 216-227, 2013 | 20 | 2013 |
| Elevated p38MAPK activity promotes neural stem cell aging L Moreno-Cugnon, O Arrizabalaga, I Llarena, A Matheu Aging (Albany NY) 12 (7), 6030, 2020 | 10 | 2020 |
| Tracking Openness and Topic Evolution of COVID-19 Publications January 2020-March 2021: Comprehensive Bibliometric and Topic Modeling Analysis M San Torcuato, N Bautista-Puig, O Arrizabalaga, E Méndez Journal of Medical Internet Research 24 (10), e40011, 2022 | 2 | 2022 |
| Rapid and Sensitive SARS-CoV-2 Detection in Saliva Samples; Basis for a High Throughput Screening C Almaraz, JM Marimón, A Sorarrain, O Arrizabalaga, D Otaegui, ... | | 2022 |
| 1; peer review: 2 approved with reservations, 1 not approved O Arrizabalaga, D Otaegui, I Vergara, J Arrizabalaga, E Méndez | | 2020 |
| Open access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in Pubmed [version 2; peer review: 2 approved, 1 approved with reservations]. O Arrizabalaga, D Otaegui, I Vergara, J Arrizabalaga, E Méndez | | 2020 |
| Instituto de Investigación Sanitaria Biodonostia-OSI Donostialdea: un modelo de innovación A Abad, J de Frutos, S Ahedo, O Arrizabalaga, A Iriondo, M Arzamendi, ... International Journal of Integrated Care 19 (4), 2019 | | 2019 |
| Biodonostia-OSI Donostialdea Health Research Institute: an innovation model A Abad, J de Frutos, S Ahedo, O Arrizabalaga, A Iriondo, M Arzamendi, ... INTERNATIONAL JOURNAL OF INTEGRATED CARE 19, 2019 | | 2019 |
| Insulin analogues to stimulate cell growth in human cancer initiating cells (CICS). E Holgado, M Cortes Semperes, O Pernia, O Arrizabalaga, ... Journal of Clinical Oncology 31 (15_suppl), 1575-1575, 2013 | | 2013 |
| Identification of Novel Therapeutic Targets in Glioblastoma I Garcia, E Carrasco-Garcia, L Garros-Regulez, P Aldaz, ... | | |
